NHS landlord Assura poised to accept £1.6bn bid from KKR consortium

GP surgery owner Assura may quit London after US giant KKR bids £1.6bn

The board of the London-listed real estate investment trust said it would be 'minded' to accept the latest proposal from KKR.

Assura likely to recommend new KKR offer to investors

Healthcare property group Assura said it has received an indicative, non-binding proposal from KKR and Stonepeak Partners for 49.4p per share. The offer, which is a premium of 31.9 per cent to the closing share price of 37.4 pence on February 13, values Assura’s share capital at about £1.6bn. Assura’s share price shot up by 14.17 per cent on the news, to 46.5p per share. The Assura board said it is likely to recommend the offer to shareholders a…

NHS landlord Assura poised to accept £1.6bn bid from KKR consortium

FTSE 250 company ‘minded to recommend’ raised offer

Assura looks set to agree new £1.61bn private equity takeover approach

The board of Assura has told US private equity giant KKR and its partner Stonepeak Partners that it is 'minded to recommend' a new £1.61bn takeover deal

Alliance Pharma's largest shareholder hikes takeover offer

DBAY Advisors controls nearly 28% of the business and made its first bid in January

UK’s Alliance Pharma accepts DBAY’s sweetened final offer

(Reuters) -Britain’s Alliance Pharma said on Monday it has agreed to a sweetened final cash proposal from asset management firm DBAY Advisors, valuing the healthcare group at about 362 million pounds ($467.5 million). The revised 64.75 pence-per-share proposal is a 3.6% increase from the previous bid of 62.5 pence, and represents a premium of 46% to the Alliance stock’s closing price on January 9, the day before the start of the offer period. In…